• PKH26 Red Fluorescent Cell Linker Kit: Application Guide

  2026-07-13

  The PKH26 Red Fluorescent Cell Linker Kit provides a membrane-specific method for labeling and tracing cells in both in vitro and in vivo research. It is ideal for tracking cell proliferation and division, but should not be used for intracellular or non-membrane applications. Strict adherence to membrane-focused protocols is essential to ensure result specificity.

• Strategic Deployment of mCherry mRNA: Mechanisms, Benchmarks

  2026-07-13

  This thought-leadership article dissects the mechanistic advantages of advanced mCherry mRNA technologies, highlights experimental benchmarks for fluorescent reporter deployment, and offers strategic guidance for translational researchers. Drawing from recent advances in nanoparticle delivery and immune modulation, it contextualizes APExBIO’s EZ Cap™ mCherry mRNA (5mCTP, ψUTP) as a next-generation tool for high-fidelity protein expression. This piece bridges molecular insight, workflow design, and future clinical implications, exceeding the scope of standard product pages.

• Lamotrigine in Cardiotoxicity Research: Integrating iPSC Mod

  2026-07-12

  Explore how Lamotrigine, a sodium channel blocker and 5-HT inhibitor, advances cardiotoxicity and epilepsy research using state-of-the-art iPSC-derived cardiomyocyte platforms. This article uniquely bridges molecular pharmacology with high-throughput hazard assessment, offering actionable insights for translational scientists.

• High-Throughput BBB Model Enhances CNS Drug Permeability Pre

  2026-07-10

  This study introduces a physiologically relevant, high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells with lysosomal trapping correction, achieving improved prediction of brain penetration for CNS drug candidates. The model shows robust correlation with in vivo brain distribution, streamlining early-stage drug screening and supporting accurate assessment of compounds like Lamotrigine.

• Dabigatran Etexilate: Clinical Review of an Oral Thrombin In

  2026-07-09

  This article examines the pivotal clinical review of dabigatran etexilate, the first oral direct thrombin inhibitor approved for stroke and VTE prevention. The study's findings highlight the prodrug's predictable pharmacology, rapid onset, and operational advantages over traditional anticoagulants in atrial fibrillation research.

• Latrunculin A in Actin–Myosin II Network Dissection: New Ass

  2026-07-09

  Explore how Latrunculin A, a reversible inhibitor of actin assembly, empowers advanced studies of the actin–myosin II network in viral pathogenesis and cell biology. This article offers unique assay guidance and translational implications, going beyond standard cytoskeleton disruption workflows.

• S63845 MCL1 Inhibitor: Precision Tools for Apoptosis Researc

  2026-07-08

  The S63845 MCL1 inhibitor enables highly selective, robust activation of mitochondrial apoptosis in MCL1-dependent cancer models. This article provides actionable guidance for experimental setup, troubleshooting, and leveraging unique workflow enhancements, bridging the latest mechanistic insights with practical laboratory execution.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Protocols & Pitfa

  2026-07-08

  PP 1 unleashes precise, nanomolar-scale control over Src-family kinase signaling, enabling advanced interrogation of oncogenic and immune pathways. This guide delivers actionable experimental workflows, troubleshooting tips, and translational insight, leveraging recent breakthroughs in metastatic prostate cancer research.

• Atorvastatin in Precision Vascular and Ferroptosis Research

  2026-07-07

  Explore how Atorvastatin, a leading HMG-CoA reductase inhibitor, is transforming cholesterol metabolism research and ferroptosis-driven oncology. This in-depth review reveals advanced assay design strategies, mechanistic insights, and translational potential not covered by existing guides.

• Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis

  2026-07-07

  This study introduces a novel prognostic model for hepatocellular carcinoma (HCC) based on ferroptosis-related genes and experimentally validates atorvastatin as an inducer of ferroptosis in HCC cells. The findings highlight a new approach for prognosis prediction and therapeutic intervention in HCC, supporting the integration of ferroptosis targeting into translational cancer research.

• 1-Phenyl-2-Pentanol Suppresses Hepatic Stellate Cell Activat

  2026-07-06

  The referenced study identifies 1-phenyl-2-pentanol from Moringa oleifera as a novel inhibitor of hepatic stellate cell activation. By targeting TGF-β1 and Wnt/β-catenin pathways, this compound demonstrates anti-fibrotic potential, providing new mechanistic insights for liver fibrosis research.

• Gallein: Precision G Protein βγ Subunit Inhibitor for GPCR R

  2026-07-06

  Gallein empowers translational researchers with a robust, selective tool for dissecting G protein βγ subunit signaling in oncology, immunology, and cardiometabolic models. Its validated applications—from modulating macrophage polarization to suppressing cancer metastasis and improving cardiac outcomes—set it apart as a next-generation small molecule for advanced GPCR pathway interrogation.

• Lactate-Driven HMGB1 Modification and Release in Sepsis

  2026-07-05

  This study uncovers how extracellular lactate promotes HMGB1 lactylation and acetylation in macrophages, driving its exosomal release during polymicrobial sepsis. The findings highlight novel metabolic-epigenetic mechanisms that enhance vascular permeability and suggest new therapeutic targets for inflammatory disease research.

• Lamotrigine for Sodium Channel & Serotonin Pathway Research

  2026-07-04

  Lamotrigine stands out as a dual-action research tool, enabling precise interrogation of sodium channel signaling and serotonin inhibition in CNS and cardiac models. This guide delivers optimized protocols, troubleshooting strategies, and actionable insights for translational workflows powered by APExBIO’s high-purity compound.

• MG-132 (Z-LLL-al): Unveiling Proteasome Inhibition in Plant

  2026-07-03

  Explore the multifaceted role of MG-132 as a selective peptide aldehyde proteasome inhibitor in apoptosis assays, cell cycle arrest studies, and the latest plant ubiquitination research. This comprehensive article uniquely bridges advanced cancer research with groundbreaking plant biology findings.

16510 records 1/1101 page Next 12345 下5页 Last page